Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Gynecol Oncol. 2016 Mar 11;141(2):348–356. doi: 10.1016/j.ygyno.2016.02.030

Figure 5. Quantitative Real-Time PCR data for total mRNA expression of NR4A1 in human patient derived xenografts of ovarian cancer.

Figure 5

Figure 5A. Clinicopathological characteristics of the primary tumor sources used for generation of PDX models. Figure 5B. Gene expression corrected to respective beta-actin expression, followed by normalization to NR4A1 delta-Ct of MCF7 in order to observe fold change compared to MCF7.